Showing 5 results for Hbv
S S Bani Aghil, S Abbasi, M Arab, M S Seyedein,
Volume 3, Issue 2 (10-2009)
Abstract
Abstract Background and objectives: Hepatitis C virus (HCV), Human immuno deficiency virus (HIV) and Hepatitis B Virus (HBV) are the three main agents of Communicable disorders transmitted by blood transfusion. The survey of these virus-caused infections in Blood donors can display epidemiology of infections in province and be useful for evaluating donors’ health. The aim of this study was serologic Study of infections caused by HBV, HCV and HIV in Blood donors of Golestan province, Iran. Material and Methods: This retrospective study was carried out on all files of blood donors, referred to Golestan Blood transfusion Services, with positive Lab results. We assess the prevalence of HBV, HCV and HIV, and demographic data of blood donors and analyzed the data by chi-square, using SPSS soft ware. Results: During 2006-2008, 128198 people have donated in Golestan province. The prevalence of HBV during 2006-2008 is respectively 1.25%, 0.95% and 0.11% HCV is 14%, 13% and of HIV is 0.0015 %( just 2 cases in 2007). The prevalence of HBV, HIV and HCV is higher in male, married and donors with high school diploma. Also the prevalence of HIV, HCV and HBV is lower in regular donors rather the first time donors. Conclusion: It seems that the prevalence of HBV and HCV is decreased during three years. This decrease can be due to physician’s supervision for selecting healthy donor and availability of donors’ medical record. Key words: Golestan Province, HIV, HCV, HBV, demographic,prevalence
Hosseini, Ma, Baniaghil, Ss, Mahmoodi, E, Bagheri Sani, Y, Dahbashi, Gh,
Volume 9, Issue 3 (9-2015)
Abstract
Abstract
Background and Objective: The donor selection and screening of blood donors for infectious factors is the main target of blood transfusion organization. this study aimed at determining the prevalence of HCV, HBV and HIV in blood donors of Golestan province , from 2012 to 2013.
Material and Methods: This cross-sectional study was conducted on all files of blood donors with positive lab results in Golestan Blood Transfusion Services. The test results, demographic characteristics and the Prevalence of hepatitis B and C and HIV were determined . The results were analyzed by SPSS software.
Results: The blood donors were 47,830 and 45,811 in 2012 and 2013, respectively. The Prevalence of HBV in 2012 was%0. 299 and in 2013 %0. 284; of HCV % 0. 06 in 2012 and % 0.05 in 2013, and the prevalence of both HCV and HIV totally was 0. 001percent in two years of study. The highest rate of positive case was among the first time donors, married and in those with less than high school education (P<0.05).
Conclusion: Regarding the high rate of positive cases among the first-time blood donors, married and less educated, it is recommended that public media be used for giving information to control communicable infections.
Keyword: HBV; HCV; HIV; Prevalence; Blood Donors .
Farzane Salarneia , Sare Zhand , Behnaz Khodabakhshi , Alijan Tabarraei , Mohammad Ali Vakili , Naeme Javid , Masoud Bazori , Abdolvahab Moradi ,
Volume 10, Issue 1 (1-2016)
Abstract
Abstract
Background and objective: Hepatitis B virus (HBV) is a DNA virus with high tendency toward hepatic tissue. There are currently about 3 million HBV-infected people and 350 to 400 million chronic carriers of this virus in the world. X protein plays a role in the over-expression of oncogenes, carcinogenicity of liver cells and overlaps with the basal core promoter of the virus. Mutations at specific nucleotides of this region increase viral replication and liver disease progression. The aim of this study was to investigate the frequency of mutations at nucleotides 1762, 1764 and 1766 of HBV X gene in patients with chronic hepatitis B and hepatitis B-related cirrhosis.
Methods: In this study, 102 patients including 68 chronic hepatitis patients and 34 patients with hepatitis B-related cirrhosis were enrolled. After DNA extraction, HBV X gene was amplified and sequenced using Semi Nested-PCR. Obtained gene sequences were compared with the standard sequence of HBV virus X gene available in the gene bank (Okamoto AB033559). Then, the mutations in the gene X of HBV were identified.
Results: Comparison of the standard sequence with sequences obtained from patients showed the presence of A1762T / G1764A mutation in 12 chronic (17.64%) and 13 cirrhotic (38.23%) patients. Also, C1766G / G1764T mutations were found in 8.23% of chronic patients and 17.64% of cirrhotic patients.
Conclusion: A1762T / G1764A mutations in the overlapping region of the basal core promoter with gene X C-terminal may lead to liver disease progression from chronic hepatitis to cirrhosis, by changing the amino acid sequence of the X protein.
Ahmad Hosseinzadeh Adli , Chiman Karami , Sareh Zhand , Reza Talei , Abdolvahab Moradi ,
Volume 10, Issue 4 (7-2016)
Abstract
ABSTRACT
Background and objectives: Globally, about one third of the population has been infected with Hepatitis B virus (HBV) and more than 400 million people have become chronically infected. Nearly, 20-25% of all carriers develop serious liver diseases such as cirrhosis, chronic hepatitis and hepatocellular carcinoma (HCC). According to the World Health Organization, HBV infection causes more than one million deaths every year. Co-infection with Human Immunodeficiency virus (HIV) and HBV is common, since both viruses have the same routes of transmission. Approximately 10 -15% of HIV-infected individuals develop chronic hepatitis B. The risk of liver diseases-related deaths is also higher in the co-infected patients. According to previous studies, mutation of the pre-core (PC) and basal-core promoter (BCP) regions may play an important role in development of HBV-related HCC and severe liver disease. The aim of this study was to investigate mutations in the BCP, PC and core regions of HBV in HIV-positive patients.
Methods: DNA was extracted using commercial kits to determine the BCP, PC/core mutations in 124 HIV/HBV co-infected patients (32.4% female and 67.6% male). Polymerase chain reaction (PCR) was performed using specific primers. The positive PCR products were subjected to automated sequencing. Then, nucleotide sequences were aligned with the standard hepatitis B sequence [Gene bank, accession number: AB033559] for mutation detection and analysis.
Results: In this study, three patients (8.1%) were HBeAg-positive and all of them were HBsAg-positive. The mean of CD4 cell count was 120 cells/mL. The mean age of the patients was 36.16 years. The important pathological mutations in HBV patients including 1752A (73%), 1773C (70.3%), 1753C (10.8%), 1896A (8.1%) and 1762T/1764A (2.7%) were detected in this study.
Conclusion: Identification of mutations in co-infected patients is of greater importance compared to mono-infected patients, because it can be useful for prediction of HCC-related mutations. Co-infection with HIV has important effects on the natural history of HBV infection, and creates different mutational patterns compared to mono-infected patients.
Keywords: HBV, HIV, Mutation.
Ali Vaez, Hadi Razavi Niko, Seyyede Delafruz Hosseini, Elham Mobasheri, Alijan Tabarraei,
Volume 17, Issue 5 (9-2023)
Abstract
Background: The hepatitis B virus (HBV) is a major public health problem worldwide. Vertical and horizontal transmission of HBV could affect neonates and partners. This transmission can vary in populations. Also, high-risk behaviors and clinical records affect the transmission of this virus. Due to the lack of information on vaginal discharge related to HBV in the north of Iran, we aimed to assess the presence of HBV in pregnant women's vaginal secretion referred to Sayyad Shirazi Hospital in Gorgan City, north of Iran.
Methods: This cross-sectional study was performed on 315 cervicovaginal lavages from pregnant women. Viral DNA was extracted, and the gene fragments of the virus were checked by polymerase chain reaction (PCR). Clinical, demographic, and behavioral data were entered into SPSS version 16. The chi-square tests were used to determine any association between categorical data.
Results: Hepatitis B virus DNA was detected in 2.2% (7/315) of samples. The age range of patients was from 14 to 43 years. Anal sex (P = 0.043) and not using a condom (P = 0.047) were significantly associated with HBV-positive cases. Abortion, unusual discharge, and some other clinical and demographic information showed no related statistical correlation.
Conclusion: The results showed a similar rate of infection in the general Iranian population. In pregnant women, the risk of HBV transmission and chronic HBV can be critical in newborns; therefore, it is strongly recommended to conduct screening and provide management for women during pregnancy.
